Cadila On Prowl Surpasses Lupin By Around Rs 3000 Cr In M-Cap


Pharma stocks are gaining grounds on the bourses in Wednesday’s trading session. Cadila Healthcare was the buzzing stock on the bourses. It was the most active stock by value in the afternoon hours on Wednesday.

The stock has touched its fresh 52-week high of Rs 540 per share in the afternoon hours on Wednesday and was trading firm holding its gains.

According to market capitalisation, Sun Pharmaceuticals was the top company as of June 6, 2017. Second top position was held by Lupin in the list of top pharma companies by M-cap.

According to today’s movement in the pharma stocks, Cadila Healthcare has surged by over 8% and crossed Lupin to take the second position in the list of top pharma companies by M-cap. As per Cadila’s fresh 52-week high on BSE, the market capitalisation of the company stood at Rs 55218 cr. However, Lupin’s intraday high was Rs 1165.95 per share and its M-cap as per intraday high stood at Rs 52623.18 cr lower that the M-cap of Cadila Healthcare Limited.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: